SCHEMBL23770609

SCHEMBL23770609

Nc1cccc(SNc2ccc(Cl)c(-c3ccccc3C3CC3)n2)n1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 3/20 0.32
CDK9 P50750 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770389 0.90 SCN9A (0.33) CCNT1CDK9
SCHEMBL23770412 0.89 CCNT1 (0.34) CCNT1CDK9
SCHEMBL23770414 0.86 ALOX5AP (0.34) CCNT1CDK9
SCHEMBL23770409 0.86 BACE1 (0.35)
SCHEMBL23770675 0.84 TRPA1 (0.35)
SCHEMBL23770590 0.84 ADORA2A (0.35)
SCHEMBL23770584 0.83 GABRA1 (0.34)
SCHEMBL23770415 0.83 ADORA2A (0.34)
SCHEMBL23770577 0.82 CDK9 (0.33) CCNT1CDK9
SCHEMBL23770769 0.80 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed